ArabicChineseEnglishFrenchRussianSpanish
WHO home
All WHO This site only
 

Medicines

  WHO > Programmes and projects > Medicines > Areas of work > Norms and Standards: Quality, safety and efficacy of medicines > Quality assurance

Quality assurance

Quality assurance is a wide ranging concept covering all matters that individually or collectively influence the quality of a product. With regard to pharmaceuticals, quality assurance can be divided into four major areas: quality control, production, distribution, and inspections. The development of norms, standards and guidelines to promote quality assurance is an integral part of WHO’s Constitution and has been endorsed and supported through numerous World Health Assembly resolutions, and more recently in those on the Revised Drug Strategy.

:: Quality assurance of pharmaceuticals: Meeting a major public health challenge [pdf 661kb]

:: Production
:: Distribution
:: Inspections
:: Quality control
:: Related regulatory standards
:: Current projects

Quality Assurance terminology

:: Quality Assurance of Medicines Terminology Database [pdf 292kb]
:: QAS Terminology db [pdf 408kb]

Norms, standards and guidelines

Important key elements are quality assurance guidance texts in the areas of production, testing, and distribution of medicines. These include guidance on: good manufacturing practices; quality assurance for regulatory approval; prequalification of medicines, laboratories, and supply agencies; model certificates for quality assurance-related activities; quality control testing; new specifications for inclusion in the Basic Tests series and the International Pharmacopoeia; and International Chemical Reference Standards; the programme on International Nonproprietary Names (INN) which is used to identify each pharmaceutical substance or active ingredient by a unique and universally accessible name . All these elements are intended for use by national regulatory authorities, manufacturers, and other interested parties. The need to scale up access to affordable quality medicines for HIV/AIDS, TB, and malaria in developing countries has raised many challenges within the pharmaceutical world. These challenges come on top of the reality that among national regulatory authorities there is a variable capacity to interpret and apply existing norms and standards and guidelines on regulation, quality control, nomenclature, and classification of pharmaceuticals. WHO will work to strengthen and promote global norms, standards, and guidelines for the quality, safety, and efficacy of medicine.

Related links

- International Nonproprietary Names
- Drug Alerts
- Expert Committee on Specifications for Pharmaceutical Preparations

MEDICINES PUBLICATIONS

Search
Search "Medicines publications"...

Browse "Just published"...



LATEST NEWS AND EVENTS

Bibliotheca Alexandrina in Alexandria, Egypt
Third International Conference on Improving Use of Medicines (ICIUM 2011)
April 10th - 14th, 2011
Preliminary Announcement [pdf 41kb]
Conference Overview [pdf 105kb]

Fact sheet
Counterfeit medicines: a public health challenge

More news...

Drug Alerts
Full list


CONTACTS

HSS/EMP
20 Avenue Appia
1211, Geneva 27
Switzerland
Tel: EMP contacts
Email: empinfo@who.int